Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: dan oreilly who wrote (2788)	1/18/1998 6:26:00 PM
From: Afaq Sarwar	Respond to of 3906

dan oreilly, Your points are well taken. If it is a very short term game for Dr. See and Tom Waite, then the risk for them is essentially none. However, If they convert 18 million shares at 30 cents and try to sell it in a short period of time they most likely will drive down the price of the stock. So in that case their return will be relatively limited.But still they stand to make a lot without much risk. In support of my reasoning please do consider the fact that I am talking about the long term scenario only. If their objective is to see the product develop or find a suitable buyer for the company, then due to the length of time as well as the uncertainties involved, their risk begins to increase. But, obviously we do not know if they are in for the long or the short haul. We can speculate either way without any certainty for being correct. Also, at the current price the situation for the new share holders who bought below $1.0 and the existing share holders who bought at significantly higher prices, is very differet. I am glad that you came out ahead in your situation. I hope that eventually the same will happen for others as well. Thanks for sharing your comments. Afaq Sarwar